Arkolith/Insider Trading/EGRX/Form 4

Tarriff Scott

CEO, Director, 10% OwnerEAGLE PHARMACEUTICALS, INC. (EGRX) · full profile →Form 4 · filed Apr 5, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 1, 2021Tax withholding(F)16K$41.87$682K1.5M
Apr 1, 2021Option exercise(M)31K$8.78$274K1.6M
Feb 23, 2021Gift(G)16K—$01.5M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 1, 2021Option exercise(M)31K—$00

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion
G
Gift

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-025187) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML